Sentrx Business Development Team Expands

Sentrx continues to add to its Business Development staff by hiring three new outstanding solution oriented individuals.

Little Falls, NJ (I-Newswire) December 5, 2012 - Sentrx, the industry-leader in global pharmacovigilance outsourcing, is pleased to announce the hiring of three professionals to enhance its business development team.

• Craig Hatton, Director, Commercial Solutions Eastern North America, previously worked in business development and sales at Biomedical Systems, Delta Pharma, Liquent Inc. and Thomson Scientific.
• Suzette Sutton, Business Development Technical Engineer, previously employed by BSI Group – Entropy, IntelliSoft Group, Cornell/Columbia New York Presbyterian, and Fidelity Investments.
• Janice Scheider, Business Development Channel Manager, previous work experience includes various positions at Foresight Group International, and Kemper Insurance Companies.

“Adding talent to our Business Development team will pay tremendous dividends to our prospective clients, our current clients and our company” says Michael O’Gorman, CEO of Sentrx. “Craig, Suzette and Janice bring the experience and personality necessary to build strong relationships with our clients, and will play integral roles in developing valuable solutions for them,” adds O’Gorman. “Our company philosophy begins with a strong client-centric foundation, and the addition of these team members strengthens this foundation.”

Sentrx’s strategic work models and partnerships allows the company to provide professional and qualified service and support to anywhere in the world. In order to expand their scope of business to a widening national and international level and to support recent and future growth, Sentrx also plans to continue hire additional the very best healthcare professionals with specific therapeutic expertise to match customer needs.

About Sentrx

Sentrx is a leading provider of technology-enabled solutions and services for global drug safety. Its mission is to help pharmaceutical, biotechnology, medical device, and consumer health companies document the safety profile of their products during clinical development and post-approval, enabling them to minimize risks and maximize benefits. Through its multilingual Safety Response Center, Sentrx delivers a unique combination of highly skilled medical experts, exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please visit the company's website at http://www.Sentrx.com, or call 973-812-7575.